GM16826
LCL from B-Lymphocyte
Description:
ALEXANDER DISEASE
GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of the Nervous System |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
GFAP |
Chromosomal Location |
17q21 |
Allelic Variant 1 |
137780.0005; ALEXANDER DISEASE |
Identified Mutation |
ARG79CYS; In a patient with Alexander disease (203450) with onset at 3 months and death at 14 years, Brenner et al. [Nature Genet. 27: 117-120 (2001)] identified a C-to-T transition at nucleotide 249 (C249T) of the GFAP gene, leading to an arg79-to-cys amino acid substitution. Brenner et al. [Nature Genet. 27: 117-120 (2001)] found the same mutation in a patient with Alexander disease still living at the age of 7 years. |
Remarks |
Line ALX-3; at age two months was hypotonic and developed seizures; large head (53cm circumference); at 13 months had shunt placed for hydrocephalus and biopsy confirmed diagnosis; significant developmental delay; MRI showed abnormal signal white matter and basal ganglia; at age 8, in wheelchair and quite retarded; donor subject is heterozygous for a C-to-T transition at nucleotide 249 (249C>T) of the GFAP gene, which results in an arg79-to-cys amino acid substitution [ARG79CYS (R79C)]. |
Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A, Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet27(1):117-20 2001 |
PubMed ID: 11138011 |
|
Messing A, Goldman JE, Johnson AB, Brenner M, Alexander disease: new insights from genetics. J Neuropathol Exp Neurol60(6):563-73 2001 |
PubMed ID: 11398833 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|